Showing 2181-2190 of 5806 results for "".
Close Up With Emma Guttman-Yassky, MD, PhD
https://practicaldermatology.com/topics/close-up/close-up-with-emma-guttman-yassky-md-phd/23953/Patient Education Tips
https://practicaldermatology.com/topics/practice-management/patient-education-tips/23908/Improving communication with effective patient education techniques.Tailoring Topical Psoriasis Treatment
https://practicaldermatology.com/topics/psoriasis/tailoring-topical-psoriasis-treatment/23866/Customizing the approach to the individual patient often brings the best results.Top Dermatology Marketing Trends for 2023
https://practicaldermatology.com/topics/practice-management/top-dermatology-marketing-trends-for-2023/23862/Are you up to date on trends in digital marketing?Fillers and Toxins Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-and-toxins-trends/23851/A look at new and potential exciting developments in the market.Physician Spotlight: R. Rox Anderson, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-r-rox-anderson-md/23838/Physician Spotlight: Paul M. Friedman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-paul-m-friedman-md/23821/Basal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.Next Generation Environmental Protection: Antioxidants and Chelators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-environmental-protection-antioxidants-and-chelators/23802/As understanding of the pathogenesis of skin aging and carcinogenesis evolves, so do topical protective strategies.A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.